Jason Gardner
2023 - Dianthus Therapeutics
In 2023, Jason Gardner earned a total compensation of $667.6K as Former President and Chief Executive Officer at Dianthus Therapeutics, a 60% decrease compared to previous year.
Compensation breakdown
| Salary | $57,861 |
|---|---|
| Other | $609,788 |
| Total | $667,649 |
Gardner received $609.8K in other compensation, accounting for 91% of the total pay in 2023.
Gardner also received $57.9K in salary.
Rankings
In 2023, Jason Gardner's compensation ranked 1,679th out of 2,978 executives tracked by ExecPay. In other words, Gardner earned more than 43.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,679 out of 2,978 | 44th |
Division Manufacturing | 978 out of 1,637 | 40th |
Major group Chemicals And Allied Products | 622 out of 906 | 31st |
Industry group Drugs | 606 out of 869 | 30th |
Industry Pharmaceutical Preparations | 432 out of 627 | 31st |
Source: SEC filing on April 11, 2024.
Gardner's colleagues
We found six more compensation records of executives who worked with Jason Gardner at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
2023
Ryan Savitz
Dianthus Therapeutics
Chief Financial Officer
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019